EXPRESS-LAAO Protocol With the New WATCHMAN FLX Pro Device
Journal of Invasive Cardiology · 2025
DOI: 10.25270/jic/25.00081 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Journal of Invasive Cardiology, 2025. Verfasst von Marco Frazzetto und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio. Hauptthemen laut MEDLINE: Atrial Fibrillation, Atrial Appendage, Cardiac Catheterization, Septal Occluder Device.
Abstract (Originalsprache)
This study evaluates the procedural outcomes and short-term follow-up of the WATCHMAN FLX Pro left atrial appendage occlusion (LAAO) device (Boston Scientific) using the EXPRESS-LAAO protocol at a high-volume center. The new device offers enhanced features, including a 40-mm size for large anatomies, additional radiopaque markers for improved positioning, and a hemocompatible coating for faster endothelization. The EXPRESS-LAAO protocol streamlines patient management with pre-procedure computed tomography or cardiac magnetic resonance imaging, intracardiac echocardiography guidance, conscious sedation, and same-day discharge for stable patients. Between June and September 2024, 109 patients (median age 78 years, 48.6% female) underwent LAAO with the WATCHMAN FLX Pro device. Key indications included recurrent falls (33%), gastrointestinal bleeding (29.4%), and very high bleeding risk (21.1%). Procedural success was high (99.1%), with 1 case of cardiac tamponade requiring pericardiocentesis and no in-hospital complications. The 40-mm device was used in 7.3% of cases, proving essential for larger anatomies. At an average follow-up of 49.7 days, there was 1 lacunar stroke without device-related complications and 1 minor bleeding event. The study demonstrates the safety and effectiveness of the WATCHMAN FLX Pro device using the EXPRESS-LAAO protocol. The TruSteer catheter (Boston Scientific) facilitated implantations in complex anatomies, reducing the number of maneuvers. While post-LAAO imaging surveillance was a limitation, this is the first study assessing peri-procedural outcomes with the new device. Findings support its clinical utility in high-risk patients requiring LAAO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio.
- Department of Medicine, University Hospitals, Cleveland Medical Center, Cleveland, Ohio.
- Division of Cardiology, Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio. Email: steven.filby@uhhospitals.org.
Zitieren
APA
Frazzetto, M., Dallan, L. A. P., Texeira, P. S., Taieb, P., Tirelli, J., Feroze, R., Alhabdan, N., Cove, A., Saeed, Y., Ukaigwe, A., Attizzani, G., & Filby, S. J. (2025). EXPRESS-LAAO Protocol With the New WATCHMAN FLX Pro Device. Journal of Invasive Cardiology. https://doi.org/10.25270/jic/25.00081
Vancouver
Frazzetto M, Dallan LAP, Texeira PS, Taieb P, Tirelli J, Feroze R, et al. EXPRESS-LAAO Protocol With the New WATCHMAN FLX Pro Device. Journal of Invasive Cardiology. 2025. doi:10.25270/jic/25.00081
BibTeX
@article{Frazzetto2025,
author = {Frazzetto, Marco and Dallan, Luis Augusto Palma and Texeira, Pedro Soares and Taieb, Philippe and Tirelli, Julia and Feroze, Rafey and Alhabdan, Nawaf and Cove, Alexander and Saeed, Yusef and Ukaigwe, Anene and Attizzani, Guilherme and Filby, Steven J},
title = {EXPRESS-LAAO Protocol With the New WATCHMAN FLX Pro Device},
journal = {Journal of Invasive Cardiology},
year = {2025},
doi = {10.25270/jic/25.00081}
}
EUVIMED